Thus, measurement of the blood CTGF level by ELISA before liver graft procurement would provide a rapid method to reliably assess the steatosis grade and NAFLD activity from a potential donor with NAFLD. The gene discussed is CCN2; the disease is metabolic dysfunction-associated steatotic liver disease.